Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dolan

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
BMC Medicine|July 14, 2007
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx miceRichard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Journal of Hand and Microsurgery|October 27, 2025
The shield multicentre collaborative: A study of hand surgeons' intraoperative radiation exposure and techniques to limit dosingIulia Marinescu, Cian M Hehir, Ferdia Browne, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
Science Immunology|March 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoireIvan Kosik, Jefferson Da Silva Santos, Mathew Angel, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
BMC Medicine|July 14, 2007
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx miceRichard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Journal of Hand and Microsurgery|October 27, 2025
The shield multicentre collaborative: A study of hand surgeons' intraoperative radiation exposure and techniques to limit dosingIulia Marinescu, Cian M Hehir, Ferdia Browne, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
Science Immunology|March 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoireIvan Kosik, Jefferson Da Silva Santos, Mathew Angel, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 25